Five long‐acting (LA) antiretrovirals (ARVs) are currently available in a limited number of
countries worldwide for HIV‐1 prevention or treatment—cabotegravir, rilpivirine, lenacapavir …

Pharmacotherapy considerations are often a concern for transgender individuals who are
living with human immunodeficiency virus (HIV) due to concerns for drug–drug interactions …

Experience has shown the need to explicitly address human rights and gender-related
barriers in the rollout of HIV-related biomedical innovations, including “undetectable equals …

Background Long-acting injectable antiretroviral therapy (LAI-ART) represents the next
innovation in HIV therapy. Pre-implementation research is needed to develop effective …

Forty-four percent of Black transgender women are living with HIV, and many face
challenges with HIV care engagement. An HIV cure has much to offer this population …

Adherence to antiretroviral therapy (ART) is essential for the effective management of HIV,
which includes keeping the HIV viral load undetectable. This study aimed to determine …

Certain communities are disproportionately impacted by HIV due to structural factors such as
racism, discrimination/stigma, homophobia, transphobia, and poverty, which are inextricably …

Background: In the US, transgender and gender-diverse (TGD) individuals, particularly trans
feminine individuals, experience a disproportionately high burden of HIV relative to their …

ТРАНСГЕНДЕРНЫЕ МУЖЧИНЫ И НЕБИНАРНЫЕ ЛЮДИ В КОНТЕКСТЕ ВИЧ
TRANSGENDER MEN AND Page 1 ЭПИДЕМИОЛОГИЯ / EPIDEMIOLOGY УДК 616.89-008.442.36 …

This dissertation examined the continuing HIV epidemic among transgender women despite
overall national declining HIV rates. Specifically, the study sought to test a new …